These observations may explain why breast cancer incidence in individuals with Gorlin syndrome (Gorlin, 1987), who are heterozygous for germline Ptch1 loss-of-function and display higher risk for other cancers, is not higher than in the general population. This evidence concerns the gene PTCH1 and nevoid basal cell carcinoma syndrome.